Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Marion

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Revue Scientifique Et Technique (International Office of Epizootics)|August 2, 2012
Antimicrobial resistance and the guidelines of the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH)H Marion
Revue Neurologique|August 1, 2000
[Drug treatments and motor complications in advanced stage Parkinson's disease ]M H Marion
Revue Neurologique|November 20, 2021
Henry Meige: The man and his understanding of dystonia, at the turn of the 19th to 20th centuryM-H Marion
Presse Medicale (Paris, France : 1983)|March 12, 1999
[Treatment of dystonias]M H Marion
Revue Neurologique|December 6, 2023
Professor Alan B. Scott (1932-2021): "The inventor of Botox"M-H Marion
Therapie|January 1, 1984
[Significance of the adverbs used to indicate the incidence of the adverse effects of a drug]M H Marion, P Simon
Movement Disorders : Official Journal of the Movement Disorder Society|November 1, 1994
"Apraxia of lid opening," a focal eyelid dystonia: clinical study of 32 patientsP Krack, M H Marion
Plos One|December 14, 2011
Chemical defense of the eastern newt (Notophthalmus viridescens): variation in efficiency against different consumers and in different habitatsZachary H Marion, Mark E Hay
Lancet (London, England)|October 3, 1992
Continuous subcutaneous apomorphine as replacement for levodopa in severe parkinsonian patients after surgeryE Broussolle, M H Marion, P Pollak
Progress in Neuro-Psychopharmacology|January 1, 1981
Antidepressant action of lithium: proposed mechanism based upon behavioral analysis in the mouseH Frances, M H Marion, P Simon
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Revue Scientifique Et Technique (International Office of Epizootics)|August 2, 2012
Antimicrobial resistance and the guidelines of the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH)H Marion
Revue Neurologique|August 1, 2000
[Drug treatments and motor complications in advanced stage Parkinson's disease ]M H Marion
Revue Neurologique|November 20, 2021
Henry Meige: The man and his understanding of dystonia, at the turn of the 19th to 20th centuryM-H Marion
Presse Medicale (Paris, France : 1983)|March 12, 1999
[Treatment of dystonias]M H Marion
Revue Neurologique|December 6, 2023
Professor Alan B. Scott (1932-2021): "The inventor of Botox"M-H Marion
Therapie|January 1, 1984
[Significance of the adverbs used to indicate the incidence of the adverse effects of a drug]M H Marion, P Simon
Movement Disorders : Official Journal of the Movement Disorder Society|November 1, 1994
"Apraxia of lid opening," a focal eyelid dystonia: clinical study of 32 patientsP Krack, M H Marion
Plos One|December 14, 2011
Chemical defense of the eastern newt (Notophthalmus viridescens): variation in efficiency against different consumers and in different habitatsZachary H Marion, Mark E Hay
Lancet (London, England)|October 3, 1992
Continuous subcutaneous apomorphine as replacement for levodopa in severe parkinsonian patients after surgeryE Broussolle, M H Marion, P Pollak
Progress in Neuro-Psychopharmacology|January 1, 1981
Antidepressant action of lithium: proposed mechanism based upon behavioral analysis in the mouseH Frances, M H Marion, P Simon
Pageof 6